Macular Degeneration Treatment Market
Healthcare Services

Global Macular Degeneration Treatment Market Size, Forecasts, And Opportunities – Includes Macular Degeneration Treatment Industry

Learn about the global macular degeneration treatment market through The Business Research Company, which provides information on macular degeneration treatment market size, macular degeneration treatment market drivers and restraints, macular degeneration treatment market players, the COVID-19 impact on the macular degeneration treatment market, and more.


The global macular degeneration treatment market size is expected to grow from $7.55 billion in 2021 to $8.08 billion in 2022 at a compound annual growth rate (CAGR) of 7.04%. The growth in the market is mainly due to the companies’ resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global macular degeneration treatment market size is expected to reach $10.65 billion in 2026 at a CAGR of 7.15%.

The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market.


Request A Sample For The Global Macular Degeneration Treatment Market Report:


Macular Degeneration Treatment Market
Macular Degeneration Treatment Market


The macular degeneration treatment market consists of sales of macular degeneration treatment by entities (organizations, sole traders, and partnerships) that are used to treat macular degeneration eye disease. Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the backside of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). Macular degeneration treatment helps to slow the disease and prevent severe loss of vision.


Global Macular Degeneration Treatment Market Segments Include:

By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

By End-User: Ambulatory Surgical Centres, Ophthalmic Clinics, Hospitals

By Route of Administration: Oral, Injectable, Others

By Type: Wet Macular Degeneration, Dry Macular Degeneration

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America will be the largest region in the macular degeneration treatment market


The development of advanced therapies is a key trend gaining popularity in the macular degeneration treatment market. Advanced therapy, including gene therapy, for the treatment of disease has seen development in recent years, particularly within the world of inherited retinal disease.


TBRC’s macular degeneration treatment market report covers:

Major Market Players: Novartis AG, Bausch Health Companies Inc, Regenxbio Inc, F Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc, Ophthotech Corporation, StemCells Inc, Pfizer Inc, Santen Pharmaceuticals, Alimera Sciences Inc, Aerie Pharmaceutical Inc, Panoptica, Allergan Inc, Valeant Pharmaceuticals, and Rxi Pharmaceuticals.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)


The Macular Degeneration Treatment Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides macular degeneration treatment market overviews, analyzes and forecasts market size, share, macular degeneration treatment market players, macular degeneration treatment market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s macular degeneration treatment market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.


Here Is A List Of Similar Reports From The Business Research Company:

Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2022

Ophthalmic Medical Lasers Global Market Report 2022

Vision Care Devices And Equipment Global Market Report 2022


Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.


Read more about us at


Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Global Market Model:

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *